HOME >> MEDICINE >> NEWS
Radiation treatment prolonged liver cancer patients' lives, U-M study finds

ANN ARBOR, Mich. - Surgery is the most effective way to treat tumors that grow in the liver. But for most patients, the tumor is growing in a way that it can't be removed. And when that happens, few options remain.

Now, researchers at the University of Michigan Comprehensive Cancer Center are reporting success with a new method of attacking these cancerous tumors. Radiation is aimed precisely at the tumor - not the entire liver - and 400 times the normal amount of chemotherapy is fed directly to the liver. The combination delivers an intensive punch directly to the tumors while limiting exposure to normal tissue.

Of the 128 patients treated, median survival was 15.8 months, significantly longer than traditional survival rates for patients with these types of tumors. Results of the study appear in the Dec. 1 issue of the Journal of Clinical Oncology.

The researchers looked specifically at patients with bile duct cancer, liver cancer or colon cancer that had spread to the liver, all of whom were not candidates for surgery. Typical survival rates for these cancers are eight or nine months. In this study, liver cancer patients lived an average 15.2 months, bile duct cancer patients lived 13.3 months and colon cancer patients lived 17.2 months.

"The patients with metastatic colorectal cancer who were entered in this trial, for example, were for the most part out of chemotherapy options at the time of referral. These are patients that we estimate would have had a life expectancy of nine, maybe 12 months. They also did not have any surgical or other local treatment options. So a median survival of 17 months in such patients is quite a substantial improvement and definitely clinically relevant," says lead study author Edgar Ben-Josef, M.D., associate professor of radiation oncology at the U-M Medical School.

In the study, patients received radiation twice daily for two weeks, along with a continuous infusion of the chemotherapy drug
'"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
28-Nov-2005


Page: 1 2 3

Related medicine news :

1. Radiation therapy reduces cancer recurrence in older breast cancer patients
2. Radiation therapy combo cures prostate cancer long-term
3. Radiation-killed bacteria vaccine induces broad immune response in mice
4. Radiation-armed robot rapidly destroys human lung tumors
5. Radiation therapy shown to increase survival in certain lung cancer patients
6. Radiation better than surgery at preserving speech for patients with head and neck cancer
7. Radiation therapy can help spare vision in patients with melanoma of the eye
8. Radiation, chemotherapy before surgery controls rectal cancer
9. Radiation and hormone therapy after surgery cures breast cancer
10. Radiation after prostate cancer surgery increases survival
11. Fox Chase study: Radiation then tamoxifen after lumpectomy for early-stage breast cancer pts

Post Your Comments:
(Date:2/27/2015)... (PRWEB) February 27, 2015 The federal ... ) that allege use of the statin medication can ... has issued a new order pertaining discovery in the ... Bernstein Liebhard LLP comments. The Order, which was issued ... on February 25th, directs the parties to schedule certain ...
(Date:2/27/2015)... 27, 2015 On February 24 2015, Harper’s ... Botox ,” that details the development of RT001, a ... its way through FDA trials. For those afraid of needles, ... very attractive. Of course, if the drug ultimately gets FDA ... physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, the ...
(Date:2/27/2015)... The winter season is here, and with it ... grows, it can be harmful to the home and to ... of mold growth with the help of Enviro-Test. Enviro-Test, the ... the best ways to prevent mold during the winter months. ... for mold to thrive. Mold must be removed properly, otherwise ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Florida Hospital ... The Guidelines - Stroke Gold Plus hospital. In order ... 85-percent or higher adherence to all Get With The ... more consecutive 12-month intervals and achieved 75-percent or higher ... - Stroke Quality Measures. These are reporting initiatives to ...
(Date:2/27/2015)... The Nashville periodontist office, Advanced ... rising freshmen undergraduate students. , The Advanced Institute for ... many periodontal procedures such as dental implants , ... . In honor of their 25th anniversary, AIOH has ... freshmen undergraduate students. , Students interested in the ...
Breaking Medicine News(10 mins):Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Is Topical Botox the Next Big Thing? 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2
(Date:2/26/2015)... 2015  AbbVie (NYSE: ABBV ) ... its neuroscience and oncology development programs have been ... American Academy of Neurology annual meeting in ... The accepted abstracts feature results from studies evaluating ... treatments in AbbVie,s pipeline. Presentations will include Phase ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... fourth quarter and full year 2014 financial results after the ... conjunction with the release, the Company will host a conference ... Time on Thursday, March 5, 2015 to ... Interested parties may access the live conference call ...
(Date:2/26/2015)... -- Mail-service and specialty pharmacies will save ... plans $23.3 billion over the next decade, according ... Association (PCMA). "Home delivery of traditional ... ways to reduce health costs," said PCMA President ... resist efforts to restrict these cost-saving tools." ...
Breaking Medicine Technology:AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
Cached News: